Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117779 · ClinicalTrials.gov registry record
Tracking Renal Tumors After Cryoablation Evaluation
A clinical trial, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- 246
- Enrollment target
NCT01117779 is a clinical trial that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 246 participants.
The verdict
NCT01117779 was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- 246 participants
- Enrollment target
Study Summary
TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry. Subjects will be observed for five years from the date of their cryoablation procedure.
Interventions
- DEVICE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2010-07-09 |
| Est. Completion | 2020-11-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117779
The ClinicalTrials.gov registry entry for NCT01117779 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01117779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01117779 about?
NCT01117779 is a clinical study titled "Tracking Renal Tumors After Cryoablation Evaluation". TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollm...
What is the current status of trial NCT01117779?
This trial is currently terminated. The enrollment target is 246 participants. The study started on 2010-07-09. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT01117779?
The interventions under investigation include: Cryoablation (DEVICE).
Who is sponsoring clinical trial NCT01117779?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.